Bluejay Diagnostics (BJDX) shares sank 48% in premarket activity Tuesday after the company overnight said institutional investors agreed to exercise warrants at a "reduced exercise price."
The medical technology firm said the investors agreed to exercise existing warrants to purchase up to about 1.09 million shares at $3.42 apiece in cash, resulting in about $3.7 million of gross proceeds.
The sharp drop in share price premarket follows a surge of more than 119% in regular trading on Monday.
Price: 3.86, Change: -3.64, Percent Change: -48.13
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。